Certify Consulting Group | thegmpconsultant.com

Warning Letter Response Playbook

What to Do When the FDA Sends a Warning Letter to Your Dietary Supplement Company

Prepared by Jared Clark, CPGP, PMP, CMQ-OE

Don't Panic. But Don't Wait.

Receiving an FDA Warning Letter is serious — but it's not a death sentence for your business. Thousands of dietary supplement companies have received warning letters and gone on to operate successfully.

⏱ FDA Warning Letters require a written response within 15 business days of receipt. The clock starts the day the letter is delivered, not the day you read it.

Understanding What You're Dealing With

What a Warning Letter IS

•An official communication identifying specific violations of federal law
•Requires a written response explaining how you will correct each violation
•Publicly posted on FDA's website within 48–72 hours
•Can trigger follow-up inspections or legal action if not addressed

What a Warning Letter is NOT

✓Not a fine or penalty (by itself)
✓Not a product recall (though one may follow)
✓Not the end of your business relationship with FDA
✓Not confidential — it will be publicly visible

Most Common Violations That Trigger Warning Letters

• Failure to perform identity testing on incoming ingredients (§111.75)

• Inadequate or missing product specifications (§111.70)

• Master Manufacturing Records that don't meet requirements (§111.205)

• No documented CAPA system (§111.103)

• OOS results disposed without investigation (§111.320)

• Microbial contamination or adulteration findings

Phase 1 | Days 1–5

Immediate Response: Secure & Assess

Day 1: Secure and Assess

Actions:

• Preserve the original letter — note the date delivered (Day 0)
• Do not destroy or alter any related records
• Convene leadership to read the letter together
• Assign an internal point person to coordinate

Assess:

• How many observations are cited?
• Are any products specifically named?
• Is there voluntary recall language?
• Any safety-related findings (contamination, allergens)?

Day 2: Legal and Regulatory Counsel

Retain regulatory counsel or a GMP consultant experienced in warning letter responses — this is not optional. How you communicate about the warning letter can affect your legal position.

Important: Do NOT send any public communications about the letter without counsel review.

Days 3–5: Scope the Violations

Create a violation-by-violation matrix for each observation cited:

Violation	CFR Citation	Root Cause (Preliminary)	Systemic?
e.g. No identity testing	§111.75(a)(1)	No procedure existed	Yes

Phase 2 | Days 5–12

Response Drafting

The Structure FDA Expects

Your written response must address every violation cited. For each violation, include:

1. Acknowledgment — Confirm you understand the violation cited
2. Root Cause — A genuine analysis of why it occurred (not blame-shifting)
3. Immediate Corrective Actions — What you did right now (before sending this response)
4. Systemic Corrective Actions — What you changed to prevent recurrence
5. Timeline — Specific completion dates for each corrective action not yet complete
6. Supporting Documentation — Attach evidence where available (new SOPs, training records, test results)

What to Avoid in Your Response

• Do not dispute findings you cannot disprove — FDA observed what they observed
• Do not make commitments you cannot keep on the timeline you state
• Do not provide partial responses — every citation must be addressed
• Do not be vague — "we will improve our procedures" without specifics is inadequate
• Do not reference supporting documents you do not actually attach

Tone: Write in plain English. Avoid being defensive. FDA's goal is compliance — demonstrate that you share that goal. A cooperative, transparent response signals that you understand the seriousness and are committed to correction.

Phase 3 | Days 5–90

Corrective Action Execution

Priority 1 — Before Sending Response

• Halt affected processes if there is an ongoing safety risk
• Implement interim controls (e.g., 100% hold and test)
• Update or create missing SOPs that are simple to write
• Train personnel on changes already made

Priority 2 — Within 30 Days

• Establish specifications for components lacking them
• Implement formal CAPA for each cited violation
• Validate or verify inadequate test methods
• Conduct internal audit of full 21 CFR Part 111

Priority 3 — Within 60–90 Days

• Full supplier qualification program
• Equipment qualification for unqualified equipment
• Updated Master Manufacturing Records for all products
• Comprehensive personnel training program refresh

Phase 4 | Day 15

Submitting Your Response

• Submit by the deadline: 15 business days from the date of receipt

• Submit in writing via email to the FDA district office listed in the letter, with a copy to CFSAN

• Reference the warning letter number in your subject line

• Include a cover letter signed by your most senior responsible individual (owner, President, CEO, or VP Quality)

• If you need more time, contact FDA proactively before the deadline to request an extension

Corrective Action Tracker (create this before submission)

Commitment	Owner	Target Date	Completed	Evidence

5 Mistakes That Make Warning Letters Worse

Treating the response as a box-checking exercise.FDA investigators are experienced. Superficial responses lead to re-inspections and escalating action.

Failing to address root cause.Fix the system, not just the finding. The real root cause is usually deeper than the surface violation.

Overpromising timelines.A realistic 90-day timeline you meet is better than a 30-day promise you miss. FDA tracks your commitments.

Missing the deadline.15 business days moves fast. If you need more time, ask FDA before the deadline — most districts grant reasonable extensions.

Going it alone.Warning letters involve regulatory, legal, and operational complexity. The cost of external support is small compared to a failed response.

Have an Active Warning Letter?

We offer a complimentary 30-minute initial consultation for companies that have received a warning letter. No commitment required — just a straight assessment of your situation and your options.

Schedule a Free Consultation

Jared Clark, CPGP, PMP, CMQ-OE | Certify Consulting Group | thegmpconsultant.com | 858-240-4353

This playbook is for educational purposes only and does not constitute legal advice. Each warning letter situation is unique. Consult with qualified regulatory and legal counsel before submitting your response to FDA. © 2026 Certify Consulting Group.